Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture

Epilepsy Research

Volumn 23, Issue 1, 1996, Pages 1-14

  Wamil, Artur W ^b   Cheung, Helen ^c   Harris, Eric W ^c   McLean, Michael J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Astra Arcus USA   (United States)

Author keywords

Antiepileptic drug; Cultured neuron; FPL12495AA; Remacemide HCl; Sodium dependent action potential; Sustained repetitive firing

Indexed keywords

1 METHYL 1,2 DIPHENYLETHYLAMINE; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 7 CHLOROKYNURENIC ACID; DRUG METABOLITE; N METHYL DEXTRO ASPARTIC ACID; REMACEMIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EPILEPSY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD;

EID: 0030047997     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(95)00053-4     Document Type: Article

References (45)

1. Cheung, H., Kamp, D. and Harris, E., An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels, Epilepsy Res., 13 (1992) 107-112.
2. Clineschmidt, B.V., Martin, G.E. and Bunting, P.R., Anticonvulsant activity of (+)-5-methyl-10, 11-dihydro-5H-dibenzo(a,d) cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties, Drug Dev. Res., 2 (1982) 123-134.
3. Courtney, K.R. and Etter, E.G., Modulated anticonvulsant block of sodium channels in nerve and muscle, Eur. J. Pharmacol., 88 (1983) 1-9.
4. Crawford, P., Richens, A., Mawer, G., Cooper, P. and Hutchison, J.B., A double-blind placebo controlled cross-over study of remacemide hydrochloride as adjunctive therapy in patients with refractory epilepsy, Seizure, 1 (suppl. A) (1992) 7-13.
5. Foot, M. and Wallace, J., Gabapentin, In: F. Pisani, E. Perucca, G. Avanzini and A. Richens (Eds.), New Antiepileptic Drugs, Elsevier Science Publishers, Amsterdam, 1991, pp. 104-109.
6. Garske, G.E., Palmer, G.C., Napier, J.J., Griffith, R.C., Freedman, L.R., Harris, E.W., Ray, R., McCreedy, S.A., Blosser, J.C., Woodhead, J.H., White, H.S. and Swinyard, E.A., Preclinical profile of the anticonvulsant remacemide and its enantiomers in the rat, Epilepsy Res., 9 (1991) 161-174.
7. Halliwell, R.F., Peters, J.A. and Lambert, J.J., The mechanism of action and pharmacological specificity of the anticonvulsant NMDA antagonist MK-801: A voltage clamp study on neuronal cells in culture, Br. J. Pharmacol., 96 (1989) 480-494.
8. Harris, E., Stagnitto, M., Garske, G., Cregan, E., Ray, R., Julien, R., Wilson, T., Machulskis, G., Bialobok, P., White, J. and Palmer, G., Neuroprotection by remacemide, a pro-drug for noncompetitive NMDA antagonism with a high therapeutic index. In: J.-M. Kamenka and E.F. Domino (Eds.), Multiple Sigma and PCP Ligands: Mechanism for Neuromodulation and Neuroprotection?, NPP Books, Ann Arbor, MI, 1992, pp. 643-653.
9. Heyer, E.J. and Macdonald, R.L., Calcium- and sodium-dependent action potentials of mouse spinal cord and dorsal root ganglion neurons in cell culture, J. Neurophysiol., 47 (1982) 641-655.
10. Heyn, H., McCarthy, D.J., Curry, S.H., Eisman, M.S., Anders, M.W., Brain uptake and biotransformation of remacemide hydrochloride, a novel anticonvulsant, Drug Metab. Dispos., 22 (3) (1994) 443-446.
11. Hollander, M. and Wolfe, D.A., The dichotomous data problem. In: R.A. Bradley, J.S. Hunter, D.G. Kendall and G.S. Watson (Eds.), Non-parametric Statistical Methods, John Wiley and Sons, New York, 1973, pp. 15-25.
12. Hutchison, J., Remecemide hydrochloride: A novel antiepileptic drug. Progress Report on New Antiepileptic Drugs, Program and Abstract, Eilat, Israel, May 31-June 2, 1992, p. 21.
13. Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J. and Swinyard, E.A., Antiepileptic drug development. II. Anticonvulsant drug screening, Epilepsia, 19 (1978) 409-428.
14. Lampe, H. and Bigalke, H., Carbamazepine blocks NMDA-activated currents in spinal cord neurons, NeuroReport, 1 (1990) 26-28.
15. Litchfield, J.T. and Wilcoxon, F., A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-113.
16. Löscher, W. and Schmidt, D., Which animal models should be used in the search for new antiepileptic drugs? A proposal base on experimental and clinical considerations, Epilepsy Res., 2 (1988) 145-181.
17. McLean, M.J. and Macdonald, R.L., Multiple actions of phenytoin on mouse spinal cord neurons in cell culture, J.Pharmacol. Exp. Ther., 227 (1983) 779-789.
18. McLean, M.J. and Macdonald, R.L., Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture, J. Pharmacol. Exp. Ther., 237 (1986) 1001-1011.
19. McLean, M.J. and Macdonald, R.L., Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing of action potentials of mouse central neurons in cell culture, J. Pharmacol. Exp. Ther., 238 (1986) 727-738.
20. Muir, K.T. and Palmer, G.C., Remacemide. In: F. Pisani, E. Perucca, G. Avanzini and A. Richens (Eds.), New Antiepileptic Drugs (Epilepsy Res. Suppl. 3), Elsevier Science Publishers, Amsterdam, 1991, pp. 147-152.
21. Palmer, G.C., Stagnitto, M.L., Ordy, J.M., Griffith, R.C., Napier, J.J., Gentile, R.J., Woodhead, J.H., White, H.S. and Swinyard, E.A., Preclinical profile of stereoisomers of the anticonvulsant remacemide in mice, Epilepsy Res., 8 (1991) 36-48.
22. Palmer, G.C., Harris, E.W., Ray, R., Stagnitto, M.L., Schmiesing, R.J., Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetretazol seizures in mice and antagonims of MK-801 biding in vitro, Arch. Int. Pharmacodyn., 317 (1992) 16-34.
23. Palmer, G.C. Murray, R.J., Wilson, T.C.M., Eisman, M.S., Ray, R.K., Griffith, R.C., Napier, J.J., Fedorchuk, M., Stagnitto, M.L. and Garske, G.E., Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide, Epilepsy Res., 12 (1992) 9-20.
24. + channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs, Mol. Pharmacol., 40 (1991) 756-765.
25. A receptors, Ann. Neurol., 35 (1994) 229-234.
26. Riederer, P., Lange, K.W., Kornhuber, J., et al., Glutamate receptor antagonism: Neurotoxicity, anti-akinetic effects, and psychosis, J. Neural Trasm., 34 (S) (1991) 203-210.
27. Rothman, S., Noncompetitive M-methyl-D-aspartate antagonists affect multiple ionic currents, J. Pharmacol. Exp. Ther., 246 (1988) 137-142.
28. Schauf, G.L., Floyd, A.D., Marder, J., Effects of carbamazepine in the ionic conductances of myxicola giant axons, J. Pharmacol. Exp. Ther., 189 (1974) 538-543.
29. Scheyer, R.D., Cramer, J.A., Leppik, I.E., Pellock, J.M., Hochholzer, J.M., et al., Remacemide elimination after initial and chronic dosing, Clin. Pharmacol. Ther., 51 (1992) 189.
30. Schwartz, J. and Vogel, W., Diphenylhydantoin excitability reducing action in single myclinated nerve fibers, Eur. J. Pharmacol., 44 (1977) 241-249.
31. Stagnitto, M.L., Palmer, G.C., Ordy, J.M., Griffith, R.C., Napier, J.J., Becker, C.N., Gentile, R.J., Garske, G.E., Frankenheim, J.M., Woodhead, J.H., White, H.S. and Seinyard, E.A., Preclinical profile of remacemide: A novel anticonvulsant effective against maximal electroshock seizures in mice, Epilepsy Res., 7 (1990) 11-28.
32. Subramaniam, S., Donevan, S.D. and Rogawski, M.A., 1,2-Diphenyl-2-propylamine, a major metabolite of the anticonvulsant remacemide, produces a stereoselective block of NMDA receptor currents, Neurosci. Abstr., 19 (1993) 717.
33. Sveinbjornsdottir, S., Sander, J.W.A.S., Upton, D., Thompson, P.J., Patsalos, P.N., Hirt, D., Emre, M., Lowe, D. and Duncan, J.S., The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy, Epilepsy Res., 16 (1993) 165-174.
34. Taylor, C.P., The anticonvulsant lamotrigine blocks sodium currents from cloned alpha-subunits of rat brain Na channels in a voltage-dependent manner, but gabapentin does not, Soc. Neurosci. Abstr., 19 (1993) 1631.
35. Van den Berg, R.J., Kok, P. and Voskuyl, R.A., Valproate and sodium currents in cultured hippocampal neurons, Exp. Brain Res., 93 (1993) 279-287.
36. VanDongen, A.M.J., Van Erp, M.G. and Voskuyl R.A., Valproate reduces excitability by blockage of sodium and potassium conductance, Epilepsia, 27 (1986) 177-182.
37. Wamil, A.W. and McLean, M.J., Effect of anticonvulsant medications on responses to NMDA by mouse central neurons in cell culture, Epilepsia, 32 (Suppl. 3) (1991) 42.
38. Wamil, A.W. and McLean, M.J., Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture, J. Pharmacol. Exp. Ther., 260 (1992) 376-383.
39. Wamil, A.W. and McLean, M.J., Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons, J. Pharmacol. Exp. Ther., 267 (1993) 218-227.
40. Wamil, A.W. and McLean, M.J., Effect of temperature on limitation by MK-801 of firing of action potentials by spinal cord neurons in cell culture, Eur. J. Pharmacol., 230 (1993) 263-269.
41. Wamil, A.W. and McLean, M.J., Limitation of gabapentin of high frequency action potential firing by mouse central neurons in cell culture, Epilepsy Res., 17 (1994) 1-11.
42. Wamil, A.W., Schmutz, M., Portet C., Feldmann, K.F. and McLean, M.J., Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures, Eur. J. Pharmacol., 271 (1994) 301-308.
43. Wilder,. B.J., Buchanan, R.A. and Serrano, E.E., Correlation of acute diphenylhydantioin intoxication with plasma levels and metabolite excretion, Neurology, 23 (1973) 1329-1333.
44. Wilson, T.C.M., Machulskis, G.E., Garske, G.E. and Harris, E.W., Anticonvulsant concentrations in CSF and serum of rats protected against MES by PR934-423A, Soc. Neurosci Abstr., 14 (1988) 1034.
45. Zona, C. and Avoli, M., Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture, Exp. Brain Res., 81 (1990) 313-317.